OlympiA Support Web Application

Welcome to the FSTRF/OlympiA Support Web Application.
The OlympiA trial is a randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy. The Frontier Science & Technology Research Foundation (FSTRF) Data Management Center (DMC) is responsible for data management of data collected from non-North American sites participating in the OlympiA trial.
Medidata Rave
Medidata Rave is an electronic data capture (EDC) system used to enter, review, modify, and submit patient data collected for the OlympiA trial.
Technical Requirements
Please check with your IT Department regarding the following: